AQST Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.39%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $429,750.00

Aquestive Therapeutics Insider Trading History Chart

Aquestive Therapeutics Share Price & Price History

^$3.93

▲ +0.03 (0.77%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Aquestive Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/15/2024	Alexander Mark Schobel	Insider	Sell	50,000	$6.00	$300,000.00	984,476
3/8/2024	Alexander Mark Schobel	Insider	Sell	25,000	$5.19	$129,750.00	1,040,371
6/14/2022	Peter E Boyd	SVP	Buy	5,000	$0.81	$4,050.00	59,532
6/8/2022	Alexander Mark Schobel	Insider	Buy	45,871	$0.96	$44,036.16	882,871
6/8/2022	Daniel Barber	CEO	Buy	91,743	$0.96	$88,073.28	193,702
6/8/2022	Lori J Braender	General Counsel	Buy	13,761	$0.96	$13,210.56	38,761
6/8/2022	Peter E Boyd	SVP	Buy	2,293	$0.96	$2,201.28	54,532

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad

This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

SEC Filings (Institutional Ownership Changes) for Aquestive Therapeutics (NASDAQ:AQST)

32.45% of Aquestive Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Aquestive Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/22/2024	PFG Investments LLC	48,000	$0.20M	0.0%	N/A	0.065%
2/13/2024	Armistice Capital LLC	3,924,000	$7.93M	0.1%	-18.3%	5.877%
2/8/2024	Essex Investment Management Co. LLC	846,167	$1.71M	0.3%	N/A	1.267%
2/7/2024	Jump Financial LLC	29,812	$60K	0.0%	N/A	0.045%
1/25/2024	Vahanian & Associates Financial Planning Inc.	591,608	$1.20M	4.7%	-18.1%	0.886%
1/16/2024	Legato Capital Management LLC	340,564	$0.69M	0.1%	N/A	0.510%
11/15/2023	Armistice Capital LLC	4,800,000	$7.34M	0.1%	+314.5%	7.189%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	247,828	$0.38M	0.0%	+14.2%	0.371%
11/13/2023	Acadian Asset Management LLC	550,484	$0.84M	0.0%	+238.8%	0.824%
8/8/2023	Kestra Private Wealth Services LLC	16,732	$28K	0.0%	N/A	0.030%
8/7/2023	Acadian Asset Management LLC	162,467	$0.27M	0.0%	N/A	0.291%
8/4/2023	HBK Sorce Advisory LLC	42,348	$70K	0.0%	-50.0%	0.076%
8/2/2023	Bank of Montreal Can	19,230	$42K	0.0%	N/A	0.034%
5/11/2023	Financial Advocates Investment Management	25,000	$28K	0.0%	-21.9%	0.045%
4/18/2023	Vahanian & Associates Financial Planning Inc.	718,908	$0.82M	2.3%	+6.0%	1.287%
2/1/2023	Vahanian & Associates Financial Planning Inc.	678,258	$0.61M	2.0%	-2.4%	1.252%
11/3/2022	Vahanian & Associates Financial Planning Inc.	695,258	$0.81M	2.8%	+24.9%	1.303%
8/11/2022	Beacon Pointe Advisors LLC	60,000	$38K	0.0%	N/A	0.112%
8/10/2022	Mackenzie Financial Corp	61,699	$39K	0.0%	N/A	0.116%
8/5/2022	Cowen AND Company LLC	124,590	$80K	0.0%	N/A	0.281%
7/27/2022	Vahanian & Associates Financial Planning Inc.	556,758	$0.36M	1.5%	+7.0%	1.257%
5/11/2022	GSA Capital Partners LLP	34,769	$91K	0.0%	-64.4%	0.083%
4/27/2022	Vahanian & Associates Financial Planning Inc.	520,158	$1.36M	3.1%	-44.1%	1.254%
4/19/2022	Graypoint LLC	413,817	$1.08M	0.1%	N/A	0.998%
2/14/2022	PDT Partners LLC	91,611	$0.36M	0.0%	+20.4%	0.228%
2/14/2022	GSA Capital Partners LLP	97,802	$0.38M	0.0%	-67.1%	0.244%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	28,382	$0.11M	0.0%	N/A	0.071%
2/4/2022	IndexIQ Advisors LLC	81,213	$0.32M	0.0%	-6.1%	0.202%
1/28/2022	Vahanian & Associates Financial Planning Inc.	929,975	$3.62M	2.9%	N/A	2.315%
12/1/2021	Balyasny Asset Management LLC	148,061	$0.65M	0.0%	N/A	0.369%
11/15/2021	Balyasny Asset Management LLC	148,061	$0.65M	0.0%	N/A	0.369%
11/15/2021	GSA Capital Partners LLP	297,229	$1.30M	0.1%	+203.9%	0.740%
11/12/2021	Renaissance Technologies LLC	189,669	$0.83M	0.0%	-22.7%	0.472%
11/12/2021	Jump Financial LLC	49,700	$0.22M	0.0%	+62.3%	0.124%
11/10/2021	Goldman Sachs Group Inc.	73,165	$0.32M	0.0%	+7.5%	0.182%
11/10/2021	IndexIQ Advisors LLC	86,461	$0.38M	0.0%	+11.1%	0.215%
11/9/2021	Barclays PLC	27,926	$0.12M	0.0%	-11.0%	0.070%
11/9/2021	BlackRock Inc.	330,946	$1.44M	0.0%	-5.7%	0.824%
9/17/2021	Virtu Financial LLC	18,521	$74K	0.0%	N/A	0.048%
8/17/2021	Millennium Management LLC	437,854	$1.74M	0.0%	N/A	1.126%
8/17/2021	Bridgeway Capital Management LLC	127,000	$0.50M	0.0%	-16.4%	0.327%
8/17/2021	Caas Capital Management LP	217,091	$0.86M	0.0%	N/A	0.558%
8/16/2021	Squarepoint Ops LLC	19,824	$79K	0.0%	N/A	0.051%
8/16/2021	LMR Partners LLP	12,090	$48K	0.0%	N/A	0.031%
8/16/2021	PDT Partners LLC	81,765	$0.33M	0.0%	N/A	0.210%
8/16/2021	Alberta Investment Management Corp	150,000	$0.60M	0.0%	N/A	0.386%
8/16/2021	Charles Schwab Investment Management Inc.	74,757	$0.30M	0.0%	-56.7%	0.192%
8/16/2021	State Street Corp	69,877	$0.28M	0.0%	-78.4%	0.180%
8/16/2021	Tibra Equities Europe Ltd	78,100	$0.31M	0.1%	N/A	0.201%
8/16/2021	Goldman Sachs Group Inc.	68,030	$0.27M	0.0%	+45.3%	0.175%
8/13/2021	Renaissance Technologies LLC	245,448	$0.97M	0.0%	N/A	0.631%
8/13/2021	Northern Trust Corp	45,454	$0.18M	0.0%	-78.6%	0.117%
8/13/2021	Jump Financial LLC	30,630	$0.12M	0.0%	N/A	0.079%
8/13/2021	Brandywine Global Investment Management LLC	125,416	$0.50M	0.0%	-7.9%	0.323%
8/13/2021	Latash Investments LLC	243,134	$0.97M	0.6%	N/A	0.625%
8/13/2021	Geode Capital Management LLC	219,642	$0.87M	0.0%	-38.1%	0.565%
8/13/2021	Vanguard Group Inc.	1,046,078	$4.15M	0.0%	+22.1%	2.690%
8/12/2021	JPMorgan Chase & Co.	125,411	$0.50M	0.0%	+238.3%	0.323%
8/12/2021	Bank of Montreal Can	21,020	$87K	0.0%	+365.6%	0.054%
8/12/2021	Ergoteles LLC	90,900	$0.36M	0.0%	N/A	0.234%
8/11/2021	Bank of New York Mellon Corp	115,723	$0.46M	0.0%	-29.5%	0.298%
8/11/2021	Susquehanna Fundamental Investments LLC	15,644	$62K	0.0%	N/A	0.040%
8/10/2021	Cresset Asset Management LLC	25,000	$99K	0.0%	N/A	0.064%
8/6/2021	HighTower Advisors LLC	126,805	$0.50M	0.0%	+84.8%	0.347%
8/5/2021	GSA Capital Partners LLP	97,801	$0.39M	0.0%	-52.9%	0.267%
8/4/2021	IndexIQ Advisors LLC	77,801	$0.31M	0.0%	-13.0%	0.213%
8/3/2021	Financial Advocates Investment Management	17,000	$67K	0.0%	+30.8%	0.046%
6/17/2021	Geneos Wealth Management Inc.	23,300	$94K	0.0%	N/A	0.064%
5/18/2021	Morgan Stanley	358,042	$1.86M	0.0%	+929.7%	0.978%
5/18/2021	Jane Street Group LLC	13,360	$69K	0.0%	-76.5%	0.037%
5/17/2021	Nuveen Asset Management LLC	764,217	$3.97M	0.0%	+43.9%	2.088%
5/17/2021	Goldman Sachs Group Inc.	46,826	$0.24M	0.0%	-8.5%	0.128%
5/14/2021	XTX Topco Ltd	10,970	$57K	0.0%	N/A	0.030%
5/13/2021	Trexquant Investment LP	10,227	$53K	0.0%	N/A	0.028%
5/13/2021	Barclays PLC	16,612	$86K	0.0%	+159.0%	0.045%
5/13/2021	Bank of New York Mellon Corp	164,259	$0.85M	0.0%	+82.5%	0.449%
5/13/2021	Massachusetts Financial Services Co. MA	54,495	$0.28M	0.0%	-10.6%	0.149%
5/12/2021	Northern Trust Corp	212,402	$1.10M	0.0%	-5.9%	0.580%
5/12/2021	Geode Capital Management LLC	354,856	$1.85M	0.0%	+13.3%	0.970%
5/12/2021	UBS Group AG	14,174	$74K	0.0%	-40.4%	0.039%
5/11/2021	Oak Grove Capital LLC	15,500	$81K	0.0%	-73.9%	0.042%
5/10/2021	HighTower Advisors LLC	68,617	$0.36M	0.0%	N/A	0.188%
5/10/2021	GSA Capital Partners LLP	207,609	$1.08M	0.2%	N/A	0.567%
5/7/2021	BlackRock Inc.	1,356,400	$7.05M	0.0%	+3.9%	3.707%
5/7/2021	IndexIQ Advisors LLC	89,390	$0.47M	0.0%	N/A	0.259%
4/26/2021	Wedbush Securities Inc.	10,000	$52K	0.0%	N/A	0.029%
2/24/2021	Virtu Financial LLC	59,050	$0.32M	0.0%	-49.6%	0.176%
2/23/2021	CWA Asset Management Group LLC	11,284	$60K	0.0%	N/A	0.034%
2/19/2021	JPMorgan Chase & Co.	38,863	$0.21M	0.0%	+187.5%	0.116%
2/17/2021	Oak Grove Capital LLC	59,500	$0.32M	0.1%	-33.1%	0.177%
2/17/2021	Jane Street Group LLC	56,752	$0.30M	0.0%	-10.1%	0.169%
2/16/2021	Squarepoint Ops LLC	42,797	$0.23M	0.0%	N/A	0.127%
2/16/2021	Nuveen Asset Management LLC	531,086	$2.84M	0.0%	+329.1%	1.580%
2/16/2021	Engineers Gate Manager LP	49,000	$0.26M	0.0%	-28.3%	0.146%
2/12/2021	Financial Advocates Investment Management	14,200	$76K	0.0%	N/A	0.042%
2/11/2021	Northern Trust Corp	225,604	$1.21M	0.0%	-2.7%	0.671%
2/11/2021	Barclays PLC	6,415	$34K	0.0%	-29.4%	0.019%
2/11/2021	Citigroup Inc.	10,138	$54K	0.0%	+418.6%	0.030%
2/10/2021	Rhumbline Advisers	19,740	$0.11M	0.0%	+17.6%	0.059%
2/10/2021	Renaissance Technologies LLC	271,800	$1.45M	0.0%	N/A	0.808%

Data available starting January 2016

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. Its proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. The company's proprietary pipeline of complex molecule product includes AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; and Anaphylm, an epinephrine sublingual film for the emergency treatment of allergic reactions, including anaphylaxis. In addition, it develops Adrenaverse, an epinephrine prodrug platform. The company was incorporated in 2004 and is headquartered in Warren, New Jersey.

Today's Range

Now: $3.93

$3.78

$4.01

50 Day Range

MA: $4.14

$2.51

$6.09

52 Week Range

Now: $3.93

$1.15

$6.23

Volume

1,919,335 shs

Average Volume

2,186,871 shs

Market Capitalization

$288.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.87

Who are the company insiders with the largest holdings of Aquestive Therapeutics?: Aquestive Therapeutics' top insider shareholders include:
Alexander Mark Schobel (Insider)
Daniel Barber (CEO)
Peter E Boyd (SVP)
Lori J Braender (General Counsel)
Learn More about top insider investors at Aquestive Therapeutics.
Who are the major institutional investors of Aquestive Therapeutics?: Aquestive Therapeutics' top institutional investors include:
PFG Investments LLC — 0.07%
Learn More about top institutional investors of Aquestive Therapeutics stock.
Which major investors are buying Aquestive Therapeutics stock?: Within the previous quarter, AQST stock was acquired by institutional investors including:
PFG Investments LLC
In the last year, these company insiders have bought Aquestive Therapeutics stock:
Alexander Mark Schobel (Insider)
Daniel Barber (CEO)
Peter E Boyd (SVP)
Lori J Braender (General Counsel)
Learn More investors buying Aquestive Therapeutics stock.